DK3533457T3 - Anti-inflammatory pharmaceutical products - Google Patents

Anti-inflammatory pharmaceutical products Download PDF

Info

Publication number
DK3533457T3
DK3533457T3 DK18212844.7T DK18212844T DK3533457T3 DK 3533457 T3 DK3533457 T3 DK 3533457T3 DK 18212844 T DK18212844 T DK 18212844T DK 3533457 T3 DK3533457 T3 DK 3533457T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical products
inflammatory pharmaceutical
inflammatory
products
pharmaceutical
Prior art date
Application number
DK18212844.7T
Other languages
Danish (da)
Inventor
Angelo P Consalvo
Nozer M Mehta
Mauro Perretti
Jesmond Dalli
Original Assignee
Resother Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resother Pharma Aps filed Critical Resother Pharma Aps
Priority claimed from EP12799815.1A external-priority patent/EP2720707B1/en
Application granted granted Critical
Publication of DK3533457T3 publication Critical patent/DK3533457T3/en

Links

DK18212844.7T 2011-06-15 2012-06-15 Anti-inflammatory pharmaceutical products DK3533457T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161497270P 2011-06-15 2011-06-15
EP12799815.1A EP2720707B1 (en) 2011-06-15 2012-06-15 Anti-inflammatory pharmaceutical products

Publications (1)

Publication Number Publication Date
DK3533457T3 true DK3533457T3 (en) 2021-11-01

Family

ID=78371698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18212844.7T DK3533457T3 (en) 2011-06-15 2012-06-15 Anti-inflammatory pharmaceutical products

Country Status (1)

Country Link
DK (1) DK3533457T3 (en)

Similar Documents

Publication Publication Date Title
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
DK3181128T3 (en) NILOTINIB PHARMACEUTICAL COMPOSITION
DK3639872T3 (en) DRUG ADMINISTRATION DEVICE
BR112014003052A2 (en) pharmaceutical compositions
DK2922877T3 (en) IMPROVED PEPTID MEDICINES
DK2709667T3 (en) BIO-ORTHOGONAL MEDICINE ACTIVATION
DK2706982T4 (en) INTRANASAL PHARMACEUTICAL DOSAGE FORMS INCLUDING NALOXON
CO6930367A2 (en) Pharmaceutical compositions
GT201200303A (en) PHARMACEUTICAL FORMULATIONS
BR112013014644A2 (en) pharmaceutical composition and complex
CO6940426A2 (en) Pharmaceutical formulations
DK2652652T3 (en) MEDICINE ADMINISTRATION
DK2897594T3 (en) PHARMACEUTICAL COMPOSITION
DK2815752T3 (en) ORAL PHARMACEUTICAL COMPOSITION
BR112013008074A2 (en) pharmaceutical combinations
DK3178474T3 (en) Pharmaceutical formulation comprising inositol
DK3079655T3 (en) INHALABLE MEDICINAL PRODUCTS
BR112014009319A2 (en) pharmaceutical compounds
CL2014003283A1 (en) Pharmaceutical formulation
CO7010828A2 (en) Pharmaceutical preparation comprising substituted ßcyclodextrin
DK2854765T3 (en) PHARMACEUTICAL PEMETREXED SOLUTION
PL2720707T3 (en) Anti-inflammatory pharmaceutical products
CO7091176A2 (en) Pharmaceutical diagnosis
DK3473255T3 (en) PHARMACEUTICAL FORMULATION INCLUDING CICLESONIDE
DK3003401T3 (en) PHARMACEUTICAL PREPARATION